# Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

> **NCT00161265** · — · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 68 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** tissue procurement

## Key facts

- **NCT ID:** NCT00161265
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2012-08
- **Final completion:** 2016-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161265, "Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00161265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*